nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—chronic obstructive pulmonary disease	0.75	1	CbGaD
Cysteamine—SST—respiratory system—chronic obstructive pulmonary disease	0.00667	0.192	CbGeAlD
Cysteamine—SST—connective tissue—chronic obstructive pulmonary disease	0.00587	0.169	CbGeAlD
Cysteamine—SST—bronchus—chronic obstructive pulmonary disease	0.00549	0.158	CbGeAlD
Cysteamine—SST—smooth muscle tissue—chronic obstructive pulmonary disease	0.00537	0.154	CbGeAlD
Cysteamine—SST—trachea—chronic obstructive pulmonary disease	0.00493	0.142	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00344	0.0421	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00296	0.0363	CbGpPWpGaD
Cysteamine—MPO—respiratory system—chronic obstructive pulmonary disease	0.00269	0.0772	CbGeAlD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00254	0.031	CbGpPWpGaD
Cysteamine—MPO—connective tissue—chronic obstructive pulmonary disease	0.00236	0.0679	CbGeAlD
Cysteamine—MPO—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00206	0.0253	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—STAT4—chronic obstructive pulmonary disease	0.00206	0.0252	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL17A—chronic obstructive pulmonary disease	0.00203	0.0248	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00175	0.0214	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00169	0.0206	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00164	0.0201	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00162	0.0198	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00158	0.0193	CbGpPWpGaD
Cysteamine—MPO—lung—chronic obstructive pulmonary disease	0.00143	0.041	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00142	0.0174	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00136	0.0167	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00127	0.0155	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00124	0.0151	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00113	0.0139	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00113	0.0138	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.00113	0.0138	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00109	0.0134	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00108	0.0133	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—NOS2—chronic obstructive pulmonary disease	0.00106	0.0129	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000968	0.0118	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000945	0.0116	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000906	0.0111	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000896	0.011	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000861	0.0105	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000826	0.0101	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000794	0.00972	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000729	0.00892	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.000722	0.00884	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000715	0.00875	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000709	0.00868	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000705	0.00863	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000705	0.00862	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000688	0.00842	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.000686	0.0084	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00068	0.00832	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000676	0.00828	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000673	0.00503	CcSEcCtD
Cysteamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000673	0.00502	CcSEcCtD
Cysteamine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000672	0.00502	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000668	0.00499	CcSEcCtD
Cysteamine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000667	0.00498	CcSEcCtD
Cysteamine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00494	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000657	0.00803	CbGpPWpGaD
Cysteamine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000638	0.00476	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000634	0.00776	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000633	0.00473	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000621	0.0076	CbGpPWpGaD
Cysteamine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00463	CcSEcCtD
Cysteamine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.00462	CcSEcCtD
Cysteamine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000615	0.00459	CcSEcCtD
Cysteamine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000614	0.00459	CcSEcCtD
Cysteamine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000612	0.00457	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000608	0.00744	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000604	0.00739	CbGpPWpGaD
Cysteamine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.0006	0.00448	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000598	0.00732	CbGpPWpGaD
Cysteamine—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00445	CcSEcCtD
Cysteamine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000593	0.00443	CcSEcCtD
Cysteamine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000581	0.00434	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000579	0.00708	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000579	0.00708	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000574	0.00702	CbGpPWpGaD
Cysteamine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00057	0.00426	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00056	0.00685	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000559	0.00684	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000558	0.00683	CbGpPWpGaD
Cysteamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000555	0.00415	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000555	0.00679	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000553	0.00677	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000548	0.00671	CbGpPWpGaD
Cysteamine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000548	0.00409	CcSEcCtD
Cysteamine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000546	0.00408	CcSEcCtD
Cysteamine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000546	0.00408	CcSEcCtD
Cysteamine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00406	CcSEcCtD
Cysteamine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00406	CcSEcCtD
Cysteamine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00405	CcSEcCtD
Cysteamine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00405	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00054	0.00661	CbGpPWpGaD
Cysteamine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000539	0.00402	CcSEcCtD
Cysteamine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00399	CcSEcCtD
Cysteamine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00397	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000532	0.00651	CbGpPWpGaD
Cysteamine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00396	CcSEcCtD
Cysteamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00053	0.00395	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000526	0.00643	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—chronic obstructive pulmonary disease	0.000524	0.00641	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000518	0.00634	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Cysteamine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00385	CcSEcCtD
Cysteamine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00385	CcSEcCtD
Cysteamine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00383	CcSEcCtD
Cysteamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000512	0.00382	CcSEcCtD
Cysteamine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00382	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000511	0.00625	CbGpPWpGaD
Cysteamine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00378	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000504	0.00377	CcSEcCtD
Cysteamine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00373	CcSEcCtD
Cysteamine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00373	CcSEcCtD
Cysteamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00368	CcSEcCtD
Cysteamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00367	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00049	0.00599	CbGpPWpGaD
Cysteamine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00365	CcSEcCtD
Cysteamine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000488	0.00364	CcSEcCtD
Cysteamine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000488	0.00364	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000487	0.00596	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000486	0.00594	CbGpPWpGaD
Cysteamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000485	0.00362	CcSEcCtD
Cysteamine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000484	0.00362	CcSEcCtD
Cysteamine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.00362	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000483	0.00591	CbGpPWpGaD
Cysteamine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00359	CcSEcCtD
Cysteamine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00359	CcSEcCtD
Cysteamine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00356	CcSEcCtD
Cysteamine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00354	CcSEcCtD
Cysteamine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000473	0.00353	CcSEcCtD
Cysteamine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00353	CcSEcCtD
Cysteamine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00353	CcSEcCtD
Cysteamine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00352	CcSEcCtD
Cysteamine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00349	CcSEcCtD
Cysteamine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00349	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000467	0.00571	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000463	0.00566	CbGpPWpGaD
Cysteamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00046	0.00343	CcSEcCtD
Cysteamine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00342	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000455	0.00556	CbGpPWpGaD
Cysteamine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00339	CcSEcCtD
Cysteamine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000454	0.00339	CcSEcCtD
Cysteamine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00337	CcSEcCtD
Cysteamine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00337	CcSEcCtD
Cysteamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00335	CcSEcCtD
Cysteamine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00333	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000445	0.00544	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000444	0.00543	CbGpPWpGaD
Cysteamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.0033	CcSEcCtD
Cysteamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000442	0.0033	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000442	0.00541	CbGpPWpGaD
Cysteamine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000442	0.0033	CcSEcCtD
Cysteamine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.0033	CcSEcCtD
Cysteamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00324	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000431	0.00527	CbGpPWpGaD
Cysteamine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000428	0.0032	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000427	0.00523	CbGpPWpGaD
Cysteamine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000426	0.00318	CcSEcCtD
Cysteamine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00318	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000424	0.00519	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000423	0.00518	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000422	0.00517	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.00315	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00314	CcSEcCtD
Cysteamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00312	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000416	0.0051	CbGpPWpGaD
Cysteamine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00311	CcSEcCtD
Cysteamine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.0031	CcSEcCtD
Cysteamine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000416	0.0031	CcSEcCtD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000413	0.00506	CbGpPWpGaD
Cysteamine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.00306	CcSEcCtD
Cysteamine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00041	0.00306	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00041	0.00501	CbGpPWpGaD
Cysteamine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00305	CcSEcCtD
Cysteamine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00305	CcSEcCtD
Cysteamine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00305	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00304	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00304	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000405	0.00496	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000405	0.00496	CbGpPWpGaD
Cysteamine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00302	CcSEcCtD
Cysteamine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00302	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00298	CcSEcCtD
Cysteamine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00297	CcSEcCtD
Cysteamine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00293	CcSEcCtD
Cysteamine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00293	CcSEcCtD
Cysteamine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00293	CcSEcCtD
Cysteamine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00289	CcSEcCtD
Cysteamine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00288	CcSEcCtD
Cysteamine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00288	CcSEcCtD
Cysteamine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00287	CcSEcCtD
Cysteamine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00287	CcSEcCtD
Cysteamine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00286	CcSEcCtD
Cysteamine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00285	CcSEcCtD
Cysteamine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00285	CcSEcCtD
Cysteamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00284	CcSEcCtD
Cysteamine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00282	CcSEcCtD
Cysteamine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00282	CcSEcCtD
Cysteamine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00279	CcSEcCtD
Cysteamine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00277	CcSEcCtD
Cysteamine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00272	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000361	0.00442	CbGpPWpGaD
Cysteamine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00269	CcSEcCtD
Cysteamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000359	0.00268	CcSEcCtD
Cysteamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00264	CcSEcCtD
Cysteamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00264	CcSEcCtD
Cysteamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00261	CcSEcCtD
Cysteamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00261	CcSEcCtD
Cysteamine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00258	CcSEcCtD
Cysteamine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00258	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000343	0.00419	CbGpPWpGaD
Cysteamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00255	CcSEcCtD
Cysteamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00255	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00253	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00253	CcSEcCtD
Cysteamine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00253	CcSEcCtD
Cysteamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00253	CcSEcCtD
Cysteamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00253	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000336	0.00411	CbGpPWpGaD
Cysteamine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00251	CcSEcCtD
Cysteamine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00251	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00248	CcSEcCtD
Cysteamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00248	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00033	0.00404	CbGpPWpGaD
Cysteamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00246	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000329	0.00402	CbGpPWpGaD
Cysteamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00245	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000327	0.004	CbGpPWpGaD
Cysteamine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00244	CcSEcCtD
Cysteamine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00243	CcSEcCtD
Cysteamine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00243	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000324	0.00396	CbGpPWpGaD
Cysteamine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00242	CcSEcCtD
Cysteamine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00242	CcSEcCtD
Cysteamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00241	CcSEcCtD
Cysteamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00241	CcSEcCtD
Cysteamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.0024	CcSEcCtD
Cysteamine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.0024	CcSEcCtD
Cysteamine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000321	0.0024	CcSEcCtD
Cysteamine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000321	0.0024	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00239	CcSEcCtD
Cysteamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00239	CcSEcCtD
Cysteamine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00237	CcSEcCtD
Cysteamine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00235	CcSEcCtD
Cysteamine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00233	CcSEcCtD
Cysteamine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00233	CcSEcCtD
Cysteamine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Cysteamine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Cysteamine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Cysteamine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00232	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000311	0.0038	CbGpPWpGaD
Cysteamine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00231	CcSEcCtD
Cysteamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00231	CcSEcCtD
Cysteamine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00229	CcSEcCtD
Cysteamine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00229	CcSEcCtD
Cysteamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.00229	CcSEcCtD
Cysteamine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00228	CcSEcCtD
Cysteamine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00228	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000305	0.00374	CbGpPWpGaD
Cysteamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.00228	CcSEcCtD
Cysteamine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Cysteamine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00227	CcSEcCtD
Cysteamine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00227	CcSEcCtD
Cysteamine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00223	CcSEcCtD
Cysteamine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.0022	CcSEcCtD
Cysteamine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00219	CcSEcCtD
Cysteamine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00219	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000293	0.00358	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000291	0.00356	CbGpPWpGaD
Cysteamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00216	CcSEcCtD
Cysteamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00216	CcSEcCtD
Cysteamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00216	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000287	0.00352	CbGpPWpGaD
Cysteamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00212	CcSEcCtD
Cysteamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000282	0.0021	CcSEcCtD
Cysteamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.0021	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000277	0.00339	CbGpPWpGaD
Cysteamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00206	CcSEcCtD
Cysteamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00204	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000273	0.00334	CbGpPWpGaD
Cysteamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00201	CcSEcCtD
Cysteamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00201	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000266	0.00326	CbGpPWpGaD
Cysteamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00199	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000266	0.00325	CbGpPWpGaD
Cysteamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00197	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000263	0.00322	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000262	0.00321	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000262	0.0032	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000261	0.0032	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000261	0.00319	CbGpPWpGaD
Cysteamine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00195	CcSEcCtD
Cysteamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00194	CcSEcCtD
Cysteamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00194	CcSEcCtD
Cysteamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000254	0.0019	CcSEcCtD
Cysteamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.0019	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00025	0.00306	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00025	0.00306	CbGpPWpGaD
Cysteamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00187	CcSEcCtD
Cysteamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00187	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000248	0.00303	CbGpPWpGaD
Cysteamine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00185	CcSEcCtD
Cysteamine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00185	CcSEcCtD
Cysteamine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00185	CcSEcCtD
Cysteamine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00185	CcSEcCtD
Cysteamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00184	CcSEcCtD
Cysteamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00184	CcSEcCtD
Cysteamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00183	CcSEcCtD
Cysteamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00183	CcSEcCtD
Cysteamine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00181	CcSEcCtD
Cysteamine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00181	CcSEcCtD
Cysteamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000241	0.0018	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000239	0.00292	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000238	0.00291	CbGpPWpGaD
Cysteamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00176	CcSEcCtD
Cysteamine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00175	CcSEcCtD
Cysteamine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00174	CcSEcCtD
Cysteamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00174	CcSEcCtD
Cysteamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00174	CcSEcCtD
Cysteamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00174	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000229	0.0028	CbGpPWpGaD
Cysteamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00171	CcSEcCtD
Cysteamine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00169	CcSEcCtD
Cysteamine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00168	CcSEcCtD
Cysteamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00165	CcSEcCtD
Cysteamine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00164	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000217	0.00265	CbGpPWpGaD
Cysteamine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00162	CcSEcCtD
Cysteamine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000214	0.0016	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00159	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000211	0.00259	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000208	0.00254	CbGpPWpGaD
Cysteamine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00147	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000191	0.00234	CbGpPWpGaD
Cysteamine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00142	CcSEcCtD
Cysteamine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00141	CcSEcCtD
Cysteamine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00141	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000183	0.00224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000177	0.00217	CbGpPWpGaD
Cysteamine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00131	CcSEcCtD
Cysteamine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00131	CcSEcCtD
Cysteamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000174	0.0013	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00017	0.00208	CbGpPWpGaD
Cysteamine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00126	CcSEcCtD
Cysteamine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00123	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000164	0.002	CbGpPWpGaD
Cysteamine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00122	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Cysteamine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00119	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000157	0.00192	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00117	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00115	CcSEcCtD
Cysteamine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00113	CcSEcCtD
Cysteamine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00112	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000147	0.0018	CbGpPWpGaD
Cysteamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000146	0.00179	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000141	0.00173	CbGpPWpGaD
Cysteamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00014	0.00172	CbGpPWpGaD
Cysteamine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00102	CcSEcCtD
Cysteamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000134	0.001	CcSEcCtD
Cysteamine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.001	CcSEcCtD
Cysteamine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.001	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000134	0.00164	CbGpPWpGaD
Cysteamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000995	CcSEcCtD
Cysteamine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000995	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000133	0.00163	CbGpPWpGaD
Cysteamine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000987	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00157	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000128	0.00157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000128	0.00156	CbGpPWpGaD
Cysteamine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000951	CcSEcCtD
Cysteamine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000944	CcSEcCtD
Cysteamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000944	CcSEcCtD
Cysteamine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000917	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0015	CbGpPWpGaD
Cysteamine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000913	CcSEcCtD
Cysteamine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000913	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000119	0.00146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000114	0.0014	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000851	CcSEcCtD
Cysteamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000828	CcSEcCtD
Cysteamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00079	CcSEcCtD
Cysteamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000763	CcSEcCtD
Cysteamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000734	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.79e-05	0.0012	CbGpPWpGaD
Cysteamine—Rash—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000728	CcSEcCtD
Cysteamine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000727	CcSEcCtD
Cysteamine—Headache—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000723	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.38e-05	0.00115	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.34e-05	0.00114	CbGpPWpGaD
Cysteamine—Nausea—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.000686	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.96e-05	0.0011	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.92e-05	0.00109	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.55e-05	0.00105	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.91e-05	0.000968	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.58e-05	0.000928	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.52e-05	0.00092	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.21e-05	0.000883	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.15e-05	0.000876	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.86e-05	0.000839	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.42e-05	0.000786	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.16e-05	0.000754	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.9e-05	0.000722	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.78e-05	0.000708	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.65e-05	0.000692	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.54e-05	0.000678	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.85e-05	0.000594	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.65e-05	0.00057	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.44e-05	0.000544	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.26e-05	0.000521	CbGpPWpGaD
